Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 40

    1.

    Nick Fox: aiming to prevent Alzheimer's disease.

    Kirby T.

    Lancet Neurol. 2012 Feb;11(2):128. No abstract available.

    PMID:
    22265209
    [PubMed - indexed for MEDLINE]
    2.

    Prevention of cognitive decline in ageing: dementia as the target, delayed onset as the goal.

    Fratiglioni L, Qiu C.

    Lancet Neurol. 2011 Sep;10(9):778-9. Epub 2011 Jul 19. No abstract available.

    PMID:
    21775212
    [PubMed - indexed for MEDLINE]
    3.

    NIA funding for Alzheimer's research.

    Barr RA.

    Lancet Neurol. 2011 Aug;10(8):683. No abstract available.

    PMID:
    21777823
    [PubMed - indexed for MEDLINE]
    4.

    Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

    Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW.

    Lancet Neurol. 2011 Sep;10(9):785-96. Epub 2011 Jul 27.

    PMID:
    21802369
    [PubMed - indexed for MEDLINE]
    5.

    Disentangling Alzheimer's disease.

    Duyckaerts C.

    Lancet Neurol. 2011 Sep;10(9):774-5. Epub 2011 Jul 27. No abstract available.

    PMID:
    21802368
    [PubMed - indexed for MEDLINE]
    6.

    The projected effect of risk factor reduction on Alzheimer's disease prevalence.

    Barnes DE, Yaffe K.

    Lancet Neurol. 2011 Sep;10(9):819-28. Epub 2011 Jul 19. Review.

    PMID:
    21775213
    [PubMed - indexed for MEDLINE]
    7.

    Clinical amyloid imaging in Alzheimer's disease.

    Herholz K, Ebmeier K.

    Lancet Neurol. 2011 Jul;10(7):667-70. Review.

    PMID:
    21683932
    [PubMed - indexed for MEDLINE]
    8.

    Revised criteria for Alzheimer's disease: what are the lessons for clinicians?

    Frisoni GB, Hampel H, O'Brien JT, Ritchie K, Winblad B.

    Lancet Neurol. 2011 Jul;10(7):598-601. No abstract available.

    PMID:
    21683925
    [PubMed - indexed for MEDLINE]
    9.

    Giovanni Frisoni: an innovator with his head in the cloud.

    Holmes D.

    Lancet Neurol. 2011 Jul;10(7):604. No abstract available.

    PMID:
    21683927
    [PubMed - indexed for MEDLINE]
    10.

    Mind the IGAP.

    Holmes D.

    Lancet Neurol. 2011 Jun;10(6):502-3. Epub 2011 Apr 7. No abstract available.

    PMID:
    21482190
    [PubMed - indexed for MEDLINE]
    11.

    US Alzheimer's disease researchers feel the pinch.

    Williams R.

    Lancet Neurol. 2011 May;10(5):408-9. No abstract available.

    PMID:
    21511195
    [PubMed - indexed for MEDLINE]
    12.

    PET and 18F ligands in the diagnosis of Alzheimer's disease.

    Frisoni GB.

    Lancet Neurol. 2011 May;10(5):397-9. Epub 2011 Apr 8. No abstract available.

    PMID:
    21481641
    [PubMed - indexed for MEDLINE]
    13.

    Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

    Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group.

    Lancet Neurol. 2011 May;10(5):424-35. Epub 2011 Apr 8.

    PMID:
    21481640
    [PubMed - indexed for MEDLINE]
    14.

    Error occurred: cannot get document summary

    PMID:
    21435595

    15.

    New lexicon and criteria for the diagnosis of Alzheimer's disease.

    Sohrabi HR, Weinborn M, Badcock J, Bates KA, Clarnette R, Trivedi D, Verdile G, Sutton T, Lenzo NP, Gandy SE, Martins RN.

    Lancet Neurol. 2011 Apr;10(4):299-300; author reply 300-1. No abstract available.

    PMID:
    21435594
    [PubMed - indexed for MEDLINE]
    16.

    New lexicon and criteria for the diagnosis of Alzheimer's disease.

    Giaccone G, Arzberger T, Alafuzoff I, Al-Sarraj S, Budka H, Duyckaerts C, Falkai P, Ferrer I, Ironside JW, Kovács GG, Meyronet D, Parchi P, Patsouris E, Revesz T, Riederer P, Rozemuller A, Schmitt A, Winblad B, Kretzschmar H; BrainNet Europe consortium.

    Lancet Neurol. 2011 Apr;10(4):298-9; author reply 300-1. No abstract available.

    PMID:
    21435593
    [PubMed - indexed for MEDLINE]
    17.

    The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.

    Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, Zhu X.

    Lancet Neurol. 2011 Mar;10(3):275-9. Review.

    PMID:
    21349442
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Apolipoprotein E in Alzheimer's disease and other neurological disorders.

    Verghese PB, Castellano JM, Holtzman DM.

    Lancet Neurol. 2011 Mar;10(3):241-52. Review.

    PMID:
    21349439
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Philip Scheltens: friendly face of Alzheimer's disease research.

    Williams R.

    Lancet Neurol. 2011 Mar;10(3):208. No abstract available.

    PMID:
    21349437
    [PubMed - indexed for MEDLINE]
    20.

    Big science for a big problem: ADNI enters its second phase.

    Burton A.

    Lancet Neurol. 2011 Mar;10(3):206-7. No abstract available.

    PMID:
    21349436
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk